251 - 260 of 6433 Results
Title
Year
-
OPENTitle: Self-Image in Women with Parkinson’s DiseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 3Start Page: 329End Page: 332Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-230017Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd230017?id=journal-of-parkinsons-disease%2Fjpd230017Citation Count: 6
-
OPENTitle: β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control StudyJournal Name: Clinical EpidemiologyPublisher: Informa UK LimitedVol: Volume 15Issue #:Start Page: 695End Page: 705Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/clep.s405325Best OA location URL: https://www.dovepress.com/getfile.php?fileID=90360Citation Count: 8
-
OPENTitle: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s diseaseJournal Name: Journal of Biopharmaceutical StatisticsPublisher: Informa UK LimitedVol: 35Issue #: 5Start Page: 1End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/10543406.2023.2170400Best OA location URL: https://doi.org/10.1080/10543406.2023.2170400Citation Count: 7
-
OPENTitle: Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in StrokeJournal Name: Journal of the American Heart AssociationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1161/jaha.122.026901Best OA location URL: https://escholarship.org/uc/item/3128823zCitation Count: 13
-
OPENTitle: Lack of significant Lewy pathology in 237 essential tremor brainsJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 82Issue #: 5Start Page: 452End Page: 453Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/jnen/nlad022Best OA location URL: https://doi.org/10.1093/jnen/nlad022Citation Count: 3
-
OPENTitle: Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsyJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 82Issue #: 5Start Page: 438End Page: 451Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlad025Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10117158/pdf/nlad025.pdfCitation Count: 15
-
OPENTitle: Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathyJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 82Issue #: 6Start Page: 457End Page: 466Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlad026Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10209646/pdf/nlad026.pdfCitation Count: 13
-
OPENTitle: Identification of a Putative α-synuclein Radioligand Using an in silico Similarity SearchJournal Name: Molecular Imaging and BiologyPublisher: Springer Science and Business Media LLCVol: 25Issue #: 4Start Page: 704End Page: 719Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11307-023-01814-9Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10527666/pdf/nihms-1908506.pdfCitation Count: 9
-
OPENTitle: Inhibitory synaptic loss drives network changes in multiple sclerosis: An ex vivo to in silico translational studyJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 28Issue #: 13Start Page: 2010End Page: 2019Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/13524585221125381Best OA location URL: https://doi.org/10.1177/13524585221125381Citation Count: 22
-
OPENTitle: 15th Conference Clinical Trials Alzheimer's Disease, November 29–December 2, 2022, San Francisco, CA, USA: Posters (Clinical Trial Alzheimer's Disease)Journal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: Elsevier BVVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.14283/jpad.2022.97Best OA location URL: https://doi.org/10.14283/jpad.2022.97Citation Count: 5